endocrinology

The coastal city of Jeddah will witness, on Tuesday, the activities of the second conference on diabetes and endocrinology, with the participation of a large group of doctors, pharmacists, technicians and nurses. The important health conference will be joined by King Abdulaziz Hospital and the Oncology Center in Jeddah, which will be held over two days, targeting medical personnel. The conference comes at a time when diabetes is on the rise among people, as it has become one of the most common and dangerous diseases in the modern era. To a steady increase in people infected with this disease globally.

Experts estimate that by the year 2025 AD, the number of people with diabetes will reach about 350 million in the world, of whom 80% are in poor and middle-income countries. The Kingdom''s population is considered one of the world''s most vulnerable people to this disease, as it is estimated that about 25% of adults, meaning that one person out of four Adults are at risk of contracting the disease.

The Saudi Press Agency quoted the uncle of the conference’s scientific committee chairman and the medical director of King Abdul Aziz Hospital as saying: “The participation of doctors, researchers and specialists with experience in diagnosing endocrine and diabetes diseases from various parts of the Kingdom from the Ministry of Health hospitals, university and specialist hospitals, National Guard hospitals, the armed and special forces In this conference, you will contribute to improving the level of health services provided to this large segment of society, on the practical and humanitarian levels.

He stated that the conference will present a series of lectures on everything new in relation to the diagnosis and treatment of diabetes and its complications, treatment of obesity, blood pressure, increased blood lipids, thyroid, pituitary and adrenal diseases. The specialists will also address methods of diagnosing osteoporosis, osteoporosis, vitamin D deficiency, infertility, short stature and growth hormone deficiency. And irregular blood circulation in women, such as polycystic ovary disease, menopause, and others.